Business Context and Reporting Period
This Form 8-K filing by Neuralstem, Inc. (not Palisade Bio, Inc.) reports on the results of the 2015 Annual Meeting of Stockholders held on June 19, 2015. The report was filed on June 22, 2015.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate governance events rather than a financial statement.
Material Changes
No material financial changes are reported. The filing details the successful approval of all proposals submitted to stockholders at the annual meeting.
Outlook, Risks, and Unusual Items
The filing contains no management commentary on future guidance, risks, or contingencies. It strictly documents the voting outcomes for director elections and auditor ratification.
Important Facts for Investors
- Director Elections: All three Class I Director nominees (Scott Ogilvie, Sandford Smith, and Dr. Catherine Sohn) were elected for three-year terms expiring in 2018.
- Auditor Ratification: Stockholders ratified Stegman & Company as the independent registered public accounting firm for the fiscal year ending December 31, 2015.
- Voting Results:
- Proposal 1 (Directors): Received significant support with votes for ranging from approximately 18.1 million to 19.7 million, while votes withheld were minimal (356,045 to 1,938,047).
- Proposal 2 (Auditor): Received 74,221,882 votes for, 494,701 votes against, and 458,966 abstentions.
- Company Identity: The registrant is Neuralstem, Inc., incorporated in Delaware, not Palisade Bio, Inc.